half to one-quarter of the patients. I believe that a bolder policy will have to be adopted in the future and that some, at least, of the compound fractures should be internally fixed, if a good result with full knee flexion and excellent foot movements is to be achieved. Then, these young patients will be able to squat and run normally and return to a full and active life without disability.
Acknowledgment: I am grateful to my orthopaedic colleagues in the Bristol Clinical Area who have allowed study of their cases with this injury. REFERENCE Ellis H (I 958) J. Bone Jt Surg. 40B, 42 Radioactive Colloidal Gold in the Treatment of Chronic Synovial Effusions by Professor Myer Makin FRCS and Gordon Robin FRCS (Orthopadic Department, Hadassah University Hospital, Jerusalem, Israel) Surface irradiation, using radioactive colloidal gold ('98Au) has been extensively used as a means of treating malignant ascites and pleural effusions (Andrews et al. 1953) . Investigation has shown that the intraserous radioactive material produces a degree of vascular endarteritis and subserosal fibrosis, which is the probable cause of the reduction in the quantity of fluid accumulating (MacKay 1957) . Persistent synovial effusions are similarly collections of fluid in a closed cavity lined by a thin endothelial cell layer. This resemblance prompted us to essay the effect of intra-articular radioactive gold in their treatment.
Synovial effusions are commonest and most persistent in the knee-joint and are most frequently due to osteoarthritis, rheumatoid arthritis and joint neuropathy. The cause of the effusion often cannot be determined; such cases are called 'idiopathic hydrops'. Whatever the cause the chronic effusion is always associated with chronic synovial inflammation. The object of treatment has been to produce an effect on the synovium similar to that achieved on the peritoneum and pleura, that is, a vascular endarteritis and a mild subserous fibrosis.
Intra-articular radioactive gold was not con- pathological condition in the joint but only as a means of eliminating the effusion. It was purely coincidental that a gold isotope was used; it was chosen because it is an easily available P-emitting isotope in a colloid suspension with a tissue penetration of between I and 2 mm and a short half-life of 2-7 days. The first clinical trials (Makin et al. 1963 ) were undertaken on the knee because the presence of free fluid in this joint is easy to detect; it is far removed from vital organs and thus potential radiation hazards were minimized.
A dose of 10 millicuries was used after an assessment of the synovial surface area for the knee-joint and an arbitrary dose of 3 mCi was given in ankle-joints: such a dose should give a synovial radiation effect of about 2,000 rad. The technique of injection is the same as in giving any sterile intra-articular injection. The injection is painless, without immediate after-effects. Treatment consists of a single injection of about 2-3 ml of the colloid suspension.
With this method, due to strict case selection, only 41 patients have been treated during the past eleven years. Only patients in whom other normal conservative therapy has failed have been accepted for treatment and only those with an effusion persistent for more than six months. With two exceptions, only patients over the age of 40 have been treated. The diagnoses of the patients treated were as follows: osteoarthritis 19, rheumatoid arthritis 4, villonodular synovitis 2, tabetic neuropathy 2, idiopathic hydrops 14. Five of these patients had previously undergone diagnostic synovial biopsy; 4 other patients had been advised synovectomy before undergoing this treatment and one patient had undergone bilateral synovectomy of the knee-joints, in spite of which effusions had recurred. The first 10 patients treated were admitted to hospital for observation, but lack of side-effects or complications has allowed us to treat the remaining patients on an ambulatory basis.
With most patients, following the injection, there is a marked increase in the effusion, most noticeable about a week after the injection, although it may appear earlier. Occasionally the increased effusion is sufficient to cause enough showing the intracellulai aggregation of radioactive par-ticles within the superficial synovial layer. x 185 discomfort to warrant aspiration. Resorption of the effusion usually begins during the second or third week after the injection and within six to eight weeks the effusion has usually disappeared.
Results show that of the 41 patients treated, 31 have been cured of their chronic effusion and 3 more relieved for-long periods, 2 for over eighteen months, one for over five years before the effusion recurred.
There were 7 failures and these patients may be divided into three groups: (1) Three with massive effusions, and from whom quantities of fluid up to 400 ml had been removed at repeated aspiration; it seems that in these cases the synovial radiation dose was too small for such an extensive area of synovium. (2) Two with villonodular synovitis; the treatment was ineffective probably because the n-emission of the isotope does not sufficiently penetrate into the grossly thickened synovium.
(3) Two with loculated effusions; in such cases the injected colloid does not spread evenly over the synovial surface and consequently the radiation dose is irregular; loculation is a contraindication to this method.
Although the therapeutic objective of intraarticular radioactive gold was only to reduce the amount of fluid accumulating in the joint, frequently with the reduction of fluid, pain and discomfort were relieved. However, the treatment is aimed only at the fluid; it is a treatment for one symptom, not for the causative condition. In order to assess the site and the mode of action of the radiation and its local and systemic irradiation effect, further investigations were undertaken.
Surface scintillation counts were carried out at intervals after the injection. The results showed that the greatest concentration of radioactivity remains in the vicinity of the injected joint and that there is only a small degree of centripetal lymph spread. Estimations of activity in the urine were carried out twenty-four and forty-eight hours after injection: in no case was any radioactivity detected. Joint fluid was aspirated at intervals after injection and its radioactivity assessed: it rapidly declined from 300 mCi in twenty-four hours to 3 mCi in forty-eight hours and 03 mCi in seven days.
In patients about to undergo elective aboveknee amputation, radioactive gold was injected into the knee-joint at varying times before the amputation. Immediately following the amputation, equal weights of tissues in and around the knee-joint were removed and their radioactivity measured. The results (Table 1) show that most of the activity remains in the synovial tissue and that there is little radioactivity outside the joint. It appears that following injection into the joint space, the radioactivity is rapidly eliminated from the joint fluid but remains in the region of the synovium. It does not spread to any significant extent outside the joint cavity. In 2 patients biopsy was performed before and several months after the injection: in both cases the synovium was stained a blue-grey metallic colour; the nonspecific synovitis, present in the first biopsy, had resolved and deposits of heavy metal were obvious in the sub-synovial tissue.
Animal experiments were carried out in normal animal joints. In one series, 50 ,uCi '98Au were injected into the knees of rabbits. Twenty-four hours later, surface scanning of the leg showed activity in the region of the knee-joint. Synovectomy was then performed attempting to remove only syiovial tissue. Rescanning revealed a marked reduction in activity. The specific uptake of the radioactive isotope by the synovium appeared to be confirmed. In rats, 3 pCi 198Au was injected into the knee joint. The animals were sacrificed at varying intervals following injection and autoradiographic studies showed that, after the initial deposit of the radioactive particles on the joint surface, there was a rapid transference of the radioactivity into the superficial synovial cells and later into the subsynovial layer (Figs 1, 2 and 3) .
The animal experiments confirm the clinical evidence that there is a specific synovial uptake of radioactive gold. Due to this specific uptake and the low tissue penetration of the P particles, the major portion of the radiation effect is directed against the synovium and the danger of radiation damage to surrounding tissue is minimal. After the gold has lost its activity and even for considerable periods thereafter, it appears to remain localized in the subsynovial tissue of the joint. In some ill-understood way the radiation effectively reduces the ability of a disordered synovium to secrete excessive fluid.
